Cargando…

Aggressive multiple sclerosis: a matter of measurement and timing

Detalles Bibliográficos
Autores principales:	Ellenberger, David, Flachenecker, Peter, Fneish, Firas, Frahm, Niklas, Hellwig, Kerstin, Paul, Friedemann, Stahmann, Alexander, Warnke, Clemens, Rommer, Paulus S, Zettl, Uwe K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719018/ https://www.ncbi.nlm.nih.gov/pubmed/33175163 http://dx.doi.org/10.1093/brain/awaa306

Ejemplares similares

Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
por: Frahm, Niklas, et al.
Publicado: (2022)

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry
por: Ohle, Lisa-Marie, et al.
Publicado: (2021)

Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry
por: Fneish, Firas, et al.
Publicado: (2023)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Epileptic seizures at multiple sclerosis onset and their role in disease progression
por: Grothe, Matthias, et al.
Publicado: (2023)

Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis
por: Frahm, Niklas, et al.
Publicado: (2021)

Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study
por: Frahm, Niklas, et al.
Publicado: (2023)

Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care
por: Jalusic, Kris Oliver, et al.
Publicado: (2021)

Relapsing and progressive MS: the sex-specific perspective
por: Rommer, Paulus Stefan, et al.
Publicado: (2020)

Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study
por: Zrzavy, Tobias, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
por: Frahm, Niklas, et al.
Publicado: (2022)

Comparison of employment among people with Multiple Sclerosis across Europe
por: Ellenberger, David, et al.
Publicado: (2022)

Coping behavior in multiple sclerosis—complementary and alternative medicine: A cross‐sectional study
por: Rommer, Paulus S, et al.
Publicado: (2018)

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
por: Frahm, Niklas, et al.
Publicado: (2019)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study
por: Frahm, Niklas, et al.
Publicado: (2019)

Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors
por: Frahm, Niklas, et al.
Publicado: (2019)

Vaccination in Multiple Sclerosis: Friend or Foe?
por: Zrzavy, Tobias, et al.
Publicado: (2019)

Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2021)

Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany
por: Henze, Thomas, et al.
Publicado: (2014)

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
por: Monschein, Tobias, et al.
Publicado: (2021)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study
por: Blechinger, Stephan, et al.
Publicado: (2021)

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023)

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness
por: Ehler, Johannes, et al.
Publicado: (2017)

Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis
por: Langhorst, Silvan Elias, et al.
Publicado: (2022)

Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
por: Sellner, Johann, et al.
Publicado: (2021)

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
por: Heidler, Felicita, et al.
Publicado: (2022)

Clinical Implications of Neuroplasticity – The Role of Rehabilitation in Multiple Sclerosis
por: Flachenecker, Peter
Publicado: (2015)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Petereit, Hela-Felicitas, et al.
Publicado: (2021)

Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease
por: Rath, Jakob, et al.
Publicado: (2022)

The pathophysiology of motor fatigue and fatigability in multiple sclerosis
por: Patejdl, Robert, et al.
Publicado: (2022)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 1: Empfehlungen
por: Monschein, Tobias, et al.
Publicado: (2021)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 2: Impfstofftechnologien
por: Monschein, Tobias, et al.
Publicado: (2021)

Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
por: Haker, Marie-Celine, et al.
Publicado: (2023)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
por: Hecker, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7rgo0a1m74k8iu9eatcmj56p20